Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Our Team - Sean Kuntz

Sean Kuntz

   Sean Kuntz
Manager of Scientific Development
502-569-1020 x305
skuntz@metacyte.biz

Sean Kuntz joined the MetaCyte team in 2005 and has more than five years experience in clinical development programs, most recently as a Research Scientist with Aptamera Inc., a Louisville-based start-up developing cancer therapeutics and diagnostics.

Sean has a background in clinical operations, transplantation immunology, oncology diagnostics and therapeutics.

Sean has been instrumental in compiling and packaging scientific portfolios. He is currently project director of EndoProtech, and serves on the management teams of RhinoCyte and AllTranz.

During his tenure at MetaCyte, Sean has secured development capital in excess of $9M from both venture and federal sources.

He holds a B.A. from Thomas More College and a M.S. in Microbiology and Immunology from the University of Louisville.







July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

August 25, 2009
Pierce Named Interim Head of UofL Research (External Link)

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)